A Phase 1b Trial of Prexasertib in Combination with Standard-of-Care Agents in Advanced or Metastatic CancerKathleen N. Moore, Johanna C. Bendell, Erika S. Wittchen et al.|Targeted Oncology|2021Cited by 25